BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8245483)

  • 1. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
    Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
    J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression.
    Tanaka Y; Saito K; Suzuki H; Eto S; Yamashita U
    J Immunol; 1989 Sep; 143(5):1584-90. PubMed ID: 2527267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.
    Hillion S; Garaud S; Devauchelle V; Bordron A; Berthou C; Youinou P; Jamin C
    Immunology; 2007 Nov; 122(3):371-80. PubMed ID: 17608810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies.
    Kikuchi Y; Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Miyake K; Kimoto M; Horiuchi T; Nagasawa K
    Arthritis Rheum; 2002 Dec; 46(12):3259-65. PubMed ID: 12483730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus].
    Hirose T
    Ryumachi; 1989 Aug; 29(4):277-83. PubMed ID: 2617369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.
    Mitoma H; Horiuchi T; Kimoto Y; Tsukamoto H; Uchino A; Tamimoto Y; Miyagi Y; Harada M
    Int J Mol Med; 2005 Oct; 16(4):609-15. PubMed ID: 16142394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
    Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
    J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.
    Llorente L; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Maillot MC; Durand-Gasselin I; Fourrier BM; Galanaud P; Emilie D
    Eur Cytokine Netw; 1993; 4(6):421-7. PubMed ID: 8186374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
    Huang YP; Perrin LH; Miescher PA; Zubler RH
    J Immunol; 1988 Aug; 141(3):827-33. PubMed ID: 3135313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus.
    Ueda Y; Sakane T; Tsunematsu T
    J Immunol; 1989 Dec; 143(12):3988-93. PubMed ID: 2592765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
    Ohtsuka K; Gray JD; Stimmler MM; Toro B; Horwitz DA
    J Immunol; 1998 Mar; 160(5):2539-45. PubMed ID: 9498800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH; Anderson M; Le E; La Cava A
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.